Skip to main content

Table 1 Demographic and clinical characteristics

From: Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study

Variable

Total n = 184

Gender, n (%)

 Male

81 (44.0)

 Female

103 (56.0)

Age at diagnosis, years

 Mean (SD)

60.5 (11.8)

 Median (IQR)

63.2 (51.4–70.3)

Tumor type, n (%)

 Gastrointestinal

70 (38.0)

 Breast

47 (25.5)

 Lung

29 (15.8)

 Urological/renal

18 (9.8)

 Gynecologic

9 (4.9)

 Other

11 (6.0)

Tumor stage, n (%)

 Stage II

15 (8.1)

 Stage III

26 (14.1)

 Stage IV

143 (77.7)

Type of treatment, n (%)

 Conventional chemotherapy

81 (44.0)

 Targeted therapy

103 (56.0)

Previous lines of treatment, n

 Mean (SD)

1.44 (0.96)

 Median (IQR)

1 (1–2)

Treatment duration, months

 Mean (SD)

6.8 (6.8)

 Median (IQR)

4 (2–8.5)

Previous medical conditions

 No

58 (31.5)

 Yes

126 (68.4)

ECOG Performance Status

 0 (Asymptomatic)

9 (4.9)

 1 (Symptomatic, but completely ambulatory)

142 (77.2)

 2 (Symptomatic, < 50% of time in bed)

30 (16.3)

 3 (Symptomatic, > 50% of time in bed)

3 (1.6)

  1. SD, standard deviation; IQR, interquartile range